Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 4345: Epigenetic dysregulation of transcriptional program in MLL-EEN leukemia

View through CrossRef
Abstract Aberrant DNA methylation is a typical feature of cancers, which is usually associated with deregulation of tumor suppressor genes and oncogenes. Mixed lineage leukemia (MLL)-rearranged leukemia is characterized by the presence of MLL fusion proteins resulting from chromosomal translocation between MLL and its partner genes. The MLL fusion proteins have lost the MLL histone methyltransferase SET domain, leading to alteration of epigenetic functions. Many genome-wide DNA methylation profiling studies showed significant global alteration in MLL-rearranged leukemia patients, suggesting that MLL fusion proteins mediate leukemia through dysregulation of DNA methylation status. Our previous work showed that MLL-EEN fusion protein can enhance the self-renewal capacity of murine hematopoietic progenitor cells through mediating DNA hypomethylation at HoxA family gene promoters. Nevertheless, how the aberrant DNA methylation alters the transcriptional program in MLL-EEN leukemia cells remains unclear. We performed RNA-seq to study the transcriptional program associated with MLL-EEN in murine hematopoietic stem and progenitor cells (HSPCs). We observed 1023 upregulated and 317 downregulated protein coding genes (PCGs) upon MLL-EEN overexpression. Interestingly, key regulators of DNA methylation, including Dnmt3a, Dnmt3b and Tet family genes, were downregulated, suggesting their involvement in the dysregulation of DNA methylation in MLL-EEN-driven leukemia. Gene ontology analysis showed that signaling pathways crucial to hematopoietic stem cell functions, such as Wnt and NFκb, were significantly enriched. Motif enrichment analysis also showed that the promoters of dysregulated genes were enriched with the binding sites of hematopoietic specific transcriptional factors, such as PU.1 and C/EBP family. In addition, we have identified 3016 upregulated and 1357 downregulated long non-coding RNAs (lncRNAs) in MLL-EEN HSPCs. lncRNAs, Hotairm1 and linc-p21, which was previously reported playing important roles in hematopoiesis and leukemogenesis, were also found deregulated. Notably, the deregulated lncRNAs showed positive correlation with the expression of nearby PCGs (±5 kb to lncRNAs), further demonstrating the transcriptional regulatory role of lncRNAs. MBD-seq analysis showed global DNA hypermethylation in MLL-EEN HSPC. Promoters of genes involved in myeloid differentiation and cell cycle regulation were hypermethylated, presumably associated with their downregulation mediated by MLL-EEN. We are currently investigating how the aberrant DNA methylation mediated by MLL-EEN can affect lncRNA transcription, which subsequently alters the expression of PCGs and leads to leukemic transformation. Taken together, our study provides new insights into the epigenetic regulation of transcriptional program in MLL-rearranged leukemia, which could facilitate the development of novel therapeutic strategies. Citation Format: Xianwen Yang, Yuk Man LAM, Wing Chi Lui, Ray Kit Ng. Epigenetic dysregulation of transcriptional program in MLL-EEN leukemia [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 4345. doi:10.1158/1538-7445.AM2017-4345
American Association for Cancer Research (AACR)
Title: Abstract 4345: Epigenetic dysregulation of transcriptional program in MLL-EEN leukemia
Description:
Abstract Aberrant DNA methylation is a typical feature of cancers, which is usually associated with deregulation of tumor suppressor genes and oncogenes.
Mixed lineage leukemia (MLL)-rearranged leukemia is characterized by the presence of MLL fusion proteins resulting from chromosomal translocation between MLL and its partner genes.
The MLL fusion proteins have lost the MLL histone methyltransferase SET domain, leading to alteration of epigenetic functions.
Many genome-wide DNA methylation profiling studies showed significant global alteration in MLL-rearranged leukemia patients, suggesting that MLL fusion proteins mediate leukemia through dysregulation of DNA methylation status.
Our previous work showed that MLL-EEN fusion protein can enhance the self-renewal capacity of murine hematopoietic progenitor cells through mediating DNA hypomethylation at HoxA family gene promoters.
Nevertheless, how the aberrant DNA methylation alters the transcriptional program in MLL-EEN leukemia cells remains unclear.
We performed RNA-seq to study the transcriptional program associated with MLL-EEN in murine hematopoietic stem and progenitor cells (HSPCs).
We observed 1023 upregulated and 317 downregulated protein coding genes (PCGs) upon MLL-EEN overexpression.
Interestingly, key regulators of DNA methylation, including Dnmt3a, Dnmt3b and Tet family genes, were downregulated, suggesting their involvement in the dysregulation of DNA methylation in MLL-EEN-driven leukemia.
Gene ontology analysis showed that signaling pathways crucial to hematopoietic stem cell functions, such as Wnt and NFκb, were significantly enriched.
Motif enrichment analysis also showed that the promoters of dysregulated genes were enriched with the binding sites of hematopoietic specific transcriptional factors, such as PU.
1 and C/EBP family.
In addition, we have identified 3016 upregulated and 1357 downregulated long non-coding RNAs (lncRNAs) in MLL-EEN HSPCs.
lncRNAs, Hotairm1 and linc-p21, which was previously reported playing important roles in hematopoiesis and leukemogenesis, were also found deregulated.
Notably, the deregulated lncRNAs showed positive correlation with the expression of nearby PCGs (±5 kb to lncRNAs), further demonstrating the transcriptional regulatory role of lncRNAs.
MBD-seq analysis showed global DNA hypermethylation in MLL-EEN HSPC.
Promoters of genes involved in myeloid differentiation and cell cycle regulation were hypermethylated, presumably associated with their downregulation mediated by MLL-EEN.
We are currently investigating how the aberrant DNA methylation mediated by MLL-EEN can affect lncRNA transcription, which subsequently alters the expression of PCGs and leads to leukemic transformation.
Taken together, our study provides new insights into the epigenetic regulation of transcriptional program in MLL-rearranged leukemia, which could facilitate the development of novel therapeutic strategies.
Citation Format: Xianwen Yang, Yuk Man LAM, Wing Chi Lui, Ray Kit Ng.
Epigenetic dysregulation of transcriptional program in MLL-EEN leukemia [abstract].
In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC.
Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 4345.
doi:10.
1158/1538-7445.
AM2017-4345.

Related Results

PRMT1 Activates Leukemic Stem Cell Program in MLL-Rearranged Leukemia
PRMT1 Activates Leukemic Stem Cell Program in MLL-Rearranged Leukemia
Abstract In MLL-rearranged leukemia, the Mixed Lineage Leukemia (MLL) gene undergoes chromosomal translocation that results in the loss of C-terminal histone methylt...
Abstract B35: Estradiol drives MLL gene fusions in infant acute leukemia
Abstract B35: Estradiol drives MLL gene fusions in infant acute leukemia
Abstract Translocation breakpoints involving the MLL gene linked to Infant Acute Leukemia (IAL) and therapy related acute leukemia (tAL) are tightly clustered betwee...
The Role of MLL1 and MLL2 in MLL Fusion Oncoprotein-Initiated Leukemia
The Role of MLL1 and MLL2 in MLL Fusion Oncoprotein-Initiated Leukemia
Abstract The MLL1 histone methyltransferase gene at 11q23 undergoes many distinct chromosomal translocations to yield poor prognosis leukemia. In these MLL-rearrange...
Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory
Identification of MLL partner genes in 27 patients with acute leukemia from a single cytogenetic laboratory
Chromosomal rearrangements involving the MLL gene have been associated with many different types of hematological malignancies. Fluorescent in situ hybridization with a panel of pr...
MLL-Aberrations, Associated to T-AML, Are Induced by Chemotherapy In Vivo.
MLL-Aberrations, Associated to T-AML, Are Induced by Chemotherapy In Vivo.
Abstract Background: Therapy related acute myelogenous leukemias (t-AML) are frequently observed following previous chemotherapy with alkylating agents and topoisome...
Flt3 Is Required for MLL-ENL-Induced Leukemogenesis In Vivo, but Not for LSC Function in Vitro
Flt3 Is Required for MLL-ENL-Induced Leukemogenesis In Vivo, but Not for LSC Function in Vitro
Abstract Abstract 2450 Flt3 is a type III tyrosine kinase receptor expressed on hematopoietic multipotential progenitors and more downstream progenito...
STAT3 Mutations in Large Granular Lymphocytic Leukemia
STAT3 Mutations in Large Granular Lymphocytic Leukemia
Abstract Abstract 1606 Introduction: Large granular lymphocytic leukemia (LGL leukemia) is a rare lymphoprolifera...
Novel Spliced MLL Fusions Have Been Identified Involving the MLL Partner Genes ELL, EPS15, MLLT3, and SEPT5.
Novel Spliced MLL Fusions Have Been Identified Involving the MLL Partner Genes ELL, EPS15, MLLT3, and SEPT5.
Abstract Chromosomal rearrangements of the human MLL gene are a genetic hallmark for aggressive acute leukemias. More than 60 partner genes have been characterized a...

Back to Top